Evotec and LEO Pharma form drug discovery alliance targeting dermatological conditions

Identify new leads for innovative targets in the dermatology field The alliance will use Evotec's world leading drug discovery platform

Topics: Corporate, Evotec, LEO Pharma, Drug Discovery, Dermatology, Integrated drug discovery, hit identification, Drug Development Read More

Evotec and Immuneering to collaborate on Artificial Intelligence (“AI”) driven ligand identification for rare hereditary metabolic diseases

Combination of cutting-edge IPSC and AI technologies creates opportunity to discover novel metabolic ligands to accelerate drug discovery in rare metabolic diseases

Topics: Corporate, Evotec, Immuneering, metabolic diseases, artificial intelligence, IPSC Read More

Ferring and Evotec form strategic research alliance in reproductive medicine and women’s health

Ferring accesses Evotec's integrated small molecule discovery and development platform to progress new molecules from concept to potential drug candidates Evotec is eligible for undisclosed research funding and milestones 

Topics: Corporate, Evotec, Ferring, Reproductive medicine, Women's health, small molecule, Drug Development Read More

Evotec and Celgene expand IPSC collaboration to include additional cell lines

$ 6 M payment to access additional cell lines

Topics: Corporate, Evotec, Celgene, IPSC, Induced pluripotent stem cells Read More

Evotec signs agreement with Sanofi to advance early stage academic research into novel therapeutic candidates

The creation of LAB031 is designed to translate academic research into drug discovery candidates Evotec aims to generate multiple lead candidates for Sanofi over three years across multiple therapeutic categories

Topics: Corporate, Evotec, Sanofi, LAB031, BRIDGE Read More

Evotec publishes DDup 7 – Kidney diseases 2.0

In this 7th DDup issue, we delve into the unique new kidney platforms poised to change the trajectory of kidney disease research and therapeutics development. Evotec has embarked on a novel collaboration model with Kidney Research UK, University of Bristol, University of Cambridge, University of ...

Topics: Corporate, Evotec, DDup, Kidney diseases Read More

Evotec and Almirall enter into research collaboration in the field of dermatological diseases

Collaboration is focused on first-in-class therapies to treat dermatological diseases Collaboration leverages a novel approach to disrupt cell signalling, validated by EVT Innovate

Topics: Corporate, Evotec, Almirall Read More

Evotec AG listed in MDAX

Dual-listing of Evotec AG share in TecDAX and MDAX as of 24 September 2018 

Topics: Corporate, Evotec Read More

Evotec and Celgene enter partnership in the field of targeted protein degradation

The collaboration will focus on targeted protein degradation Evotec's panomics and data analytics platforms will be leveraged Financials include upfront payment as well as significant potential milestone-based payments and royalties

Topics: Corporate, Evotec, Celgene Read More

Yumanity Therapeutics announces first clinical candidate for the potential treatment of Parkinson’s disease

First-in-Human Trials Planned for the Fourth Quarter of 2019 IND-Enabling Studies to Be Completed Utilizing Evotec INDiGO Platform

Topics: Corporate, Evotec, Yumanity Therapeutics, Parkinson's disease, INDiGO, IND Enabling Read More

Most Read

Posts by Topic